| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_08f57f2c0740d9528dece505b9bc61a4 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0647
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-545 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-16 |
| filingDate |
2019-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_50bddcba7ce57dc6400cb8d73c60dee5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e536aac1fe72aa35f05867080e2ff69
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ddb4f153f04c11978ef1f7c67852e941
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c3e4bd99eb8daea3f904946a21f17248
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d3271455c82a62e790a73afc52ba455c |
| publicationDate |
2021-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
BR-112021001190-A2 |
| titleOfInvention |
mitochondrial reinforcement therapy for primary mitochondrial diseases |
| abstract |
"mitochondrial reinforcement therapy for primary mitochondrial diseases". the present invention relates to human stem cells enriched with functional mitochondria, in which exogenous, functional and healthy mitochondria constitute at least 3% and less than 33% of the total mitochondria in mitochondrial enriched human stem cells. in addition, methods for producing such cells and their uses for the treatment of primary mitochondrial diseases are disclosed. |
| priorityDate |
2018-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |